Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family
Authors:
- Elisa Schulze SchleithoffESElisa Schulze Schleithoff
- Astrid KairatAKAstrid Kairat
- Gerry MelinoGMGerry Melino
- Wolfgang StremmelWSWolfgang Stremmel
- Moshe OrenMOMoshe Oren
- Peter H. KrammerPKPeter H. Krammer
- Martina MüllerMMMartina Müller
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 387 (2) , 399-404
Abstract
No abstract availableKeywords
Funding Information
- Helmholtz Association
This publication has 19 references indexed in Scilit:
- The role of TNF superfamily members in T-cell function and diseasesNature Reviews Immunology, 2009
- Death receptor signal transducers: nodes of coordination in immune signaling networksNature Immunology, 2009
- The Many Roles of FAS Receptor Signaling in the Immune SystemImmunity, 2009
- Therapeutic prospects for p73 and p63: Rising from the shadow of p53Drug Resistance Updates, 2008
- Living with p53, Dying of p53Cell, 2007
- p73: Friend or foe in tumorigenesisNature Reviews Cancer, 2002
- p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer DrugsJournal of Experimental Medicine, 1998
- Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.Journal of Clinical Investigation, 1997
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Monoclonal Antibody-Mediated Tumor Regression by Induction of ApoptosisScience, 1989